Variant report
Variant | esv3394460 |
---|---|
Chromosome Location | chr9:95565031-95568629 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:20)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:20 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr9:95566484-95566503 | GM19239 | blood: | n/a | n/a |
2 | CTCF | chr9:95566532-95566533 | GM19239 | blood: | n/a | n/a |
3 | CTCF | chr9:95566457-95566462 | GM19239 | blood: | n/a | n/a |
4 | CTCF | chr9:95566572-95566752 | GM19239 | blood: | n/a | n/a |
5 | CTCF | chr9:95568473-95568572 | Lung_OC | lung: | n/a | n/a |
6 | CTCF | chr9:95566534-95566570 | GM19239 | blood: | n/a | n/a |
7 | FOXA1 | chr9:95564724-95565160 | HepG2 | liver: | n/a | n/a |
8 | JUND | chr9:95564900-95565128 | HepG2 | liver: | n/a | n/a |
9 | MYC | chr9:95566387-95566505 | H1-hESC | embryonic stem cell: | n/a | n/a |
10 | MYC | chr9:95566362-95566373 | H1-hESC | embryonic stem cell: | n/a | n/a |
11 | MYC | chr9:95566658-95566750 | H1-hESC | embryonic stem cell: | n/a | n/a |
12 | MYC | chr9:95566938-95566953 | HUVEC | blood vessel: | n/a | n/a |
13 | MYC | chr9:95566974-95566986 | HUVEC | blood vessel: | n/a | n/a |
14 | NR2C2 | chr9:95566223-95567329 | GM12878 | blood: | n/a | n/a |
15 | POLR2A | chr9:95566233-95566702 | HepG2 | liver: | n/a | n/a |
16 | POLR2A | chr9:95567333-95567723 | H1-neurons | neurons: | n/a | n/a |
17 | POLR2A | chr9:95567200-95567644 | H1-neurons | neurons: | n/a | n/a |
18 | SP1 | chr9:95564759-95565126 | HepG2 | liver: | n/a | n/a |
19 | SUZ12 | chr9:95566152-95567327 | H1-hESC | embryonic stem cell: | n/a | n/a |
20 | WRNIP1 | chr9:95567230-95567333 | GM12878 | blood: | n/a | n/a |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ANKRD19P | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs142132683 | chr9:95565039-95565040 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs537860597 | chr9:95565063-95565064 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs538759509 | chr9:95565083-95565084 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs184738840 | chr9:95565100-95565101 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs556576436 | chr9:95565119-95565120 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs565573471 | chr9:95565159-95565160 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs574885960 | chr9:95565173-95565174 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs111428780 | chr9:95565193-95565194 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs554220368 | chr9:95565290-95565291 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs575627815 | chr9:95565305-95565306 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs10992473 | chr9:95565327-95565328 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs536041120 | chr9:95565338-95565339 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs536687860 | chr9:95565343-95565344 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs558213584 | chr9:95565346-95565347 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs576555273 | chr9:95565389-95565390 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs370255512 | chr9:95565408-95565409 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs540432064 | chr9:95565440-95565441 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs574988572 | chr9:95565451-95565452 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs542508706 | chr9:95565453-95565454 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs140136579 | chr9:95565457-95565458 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs530913210 | chr9:95565474-95565475 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs61626318 | chr9:95565509-95565510 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs181608758 | chr9:95565570-95565571 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs183903016 | chr9:95565588-95565589 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs528612948 | chr9:95565666-95565667 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs561500629 | chr9:95565714-95565715 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs547234123 | chr9:95565726-95565727 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs374883743 | chr9:95565797-95565798 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs145560452 | chr9:95565841-95565842 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs188685877 | chr9:95565858-95565859 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs147735545 | chr9:95565862-95565863 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs10992474 | chr9:95565979-95565980 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
33 | rs10992475 | chr9:95565998-95565999 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
34 | rs142650692 | chr9:95566051-95566052 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs374298425 | chr9:95566094-95566095 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs112486714 | chr9:95566118-95566119 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs111590599 | chr9:95566143-95566144 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs10118572 | chr9:95566176-95566177 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
39 | rs145723037 | chr9:95566190-95566191 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs202100147 | chr9:95566214-95566215 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs146609731 | chr9:95566216-95566217 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs199736088 | chr9:95566217-95566218 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs200553436 | chr9:95566221-95566222 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs180862432 | chr9:95566244-95566245 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs563951654 | chr9:95566248-95566249 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs147686830 | chr9:95566254-95566255 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs375010590 | chr9:95566257-95566258 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs113949317 | chr9:95566259-95566260 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs201446584 | chr9:95566260-95566261 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs546186196 | chr9:95566280-95566281 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Medulloblastoma | 21979893 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 16751803 | CNVD |
Myelofibrosis | 22110671 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Leukemia | 17361228 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Glioblastoma | 16823260 | CNVD |
Leukemia | 18688285 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Brain cancer | 20823417 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Heart disease | 21282601 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Lung cancer | 18438408 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Oral cancer | 21386901 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Wilms tumour | 21544195 | CNVD |
Prostate cancer | 18632612 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Gastric cancer | 17908304 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Biliary cancer | 19435499 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Cardiac fibroma | 18329553 | CNVD |
Mental retardation | 21693067 | CNVD |
Breast cancer | 17133270 | CNVD |
Basal cell nevus syndrome | 21572526 | CNVD |
Mental retardation | 19951919 | CNVD |
Retinoblastoma | 22278416 | CNVD |
9q22.3 microdeletion syndrome | 22283845 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
overgrowth syndrome | 16570072 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:95558600-95569600 | Weak transcription | Right Atrium | heart |
2 | chr9:95565800-95566000 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr9:95566400-95567000 | Active TSS | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr9:95566600-95566800 | Flanking Bivalent TSS/Enh | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
5 | chr9:95566600-95566800 | Bivalent Enhancer | H1 Derived Mesenchymal Stem Cells | ES cell derived |
6 | chr9:95566600-95567200 | Bivalent Enhancer | iPS DF 6.9 Cell Line | embryonic stem cell |
7 | chr9:95566600-95567200 | Bivalent/Poised TSS | Fetal Kidney | kidney |
8 | chr9:95566600-95569600 | Weak transcription | Pancreas | Pancrea |
9 | chr9:95566800-95567000 | Bivalent Enhancer | HSMMtube | muscle |
10 | chr9:95566800-95567200 | Bivalent Enhancer | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
11 | chr9:95567000-95567600 | Bivalent/Poised TSS | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
12 | chr9:95568200-95568400 | Bivalent Enhancer | ES-I3 Cell Line | embryonic stem cell |